These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 30718757)
1. Prenatal Betamethasone interferes with immune system development and alters target cells in autoimmune diabetes. Perna-Barrull D; Rodriguez-Fernandez S; Pujol-Autonell I; Gieras A; Ampudia-Carrasco RM; Villalba A; Glau L; Tolosa E; Vives-Pi M Sci Rep; 2019 Feb; 9(1):1235. PubMed ID: 30718757 [TBL] [Abstract][Full Text] [Related]
2. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice. Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715 [TBL] [Abstract][Full Text] [Related]
3. Immune System Remodelling by Prenatal Betamethasone: Effects on β-Cells and Type 1 Diabetes. Perna-Barrull D; Gieras A; Rodriguez-Fernandez S; Tolosa E; Vives-Pi M Front Endocrinol (Lausanne); 2020; 11():540. PubMed ID: 32849311 [TBL] [Abstract][Full Text] [Related]
6. Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice. Lo J; Xia CQ; Peng R; Clare-Salzler MJ J Immunol Res; 2018; 2018():5463879. PubMed ID: 29651443 [TBL] [Abstract][Full Text] [Related]
7. Roles of cytokines in the pathogenesis and therapy of type 1 diabetes. Rabinovitch A; Suarez-Pinzon WL Cell Biochem Biophys; 2007; 48(2-3):159-63. PubMed ID: 17709885 [TBL] [Abstract][Full Text] [Related]
8. In Vivo Insulin Peptide Autoantigen Delivery by Mannosylated Sodium Alginate Nanoparticles Delayed but Could Not Prevent the Onset of Type 1 Diabetes in Nonobese Diabetic Mice. Qu Y; Shi H; Liu M; Zhang M; Wang H; Pang L; Zhang C; Kong D; Li C Mol Pharm; 2021 Apr; 18(4):1806-1818. PubMed ID: 33734705 [TBL] [Abstract][Full Text] [Related]
9. Artesunate prevents type 1 diabetes in NOD mice mainly by inducing protective IL-4-producing T cells and regulatory T cells. Li Z; Shi X; Liu J; Shao F; Huang G; Zhou Z; Zheng P FASEB J; 2019 Jul; 33(7):8241-8248. PubMed ID: 30916998 [TBL] [Abstract][Full Text] [Related]
11. Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans. Serreze DV; Niens M; Kulik J; DiLorenzo TP Methods Mol Biol; 2016; 1438():137-51. PubMed ID: 27150089 [TBL] [Abstract][Full Text] [Related]
12. β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice. Manzoor F; Johnson MC; Li C; Samulski RJ; Wang B; Tisch R Eur J Immunol; 2017 Jan; 47(1):144-154. PubMed ID: 27859048 [TBL] [Abstract][Full Text] [Related]
13. Prenatal Betamethasone Exposure and its Impact on Pediatric Type 1 Diabetes Mellitus: A Preliminary Study in a Spanish Cohort. Perna-Barrull D; Murillo M; Real N; Gomez-Muñoz L; Rodriguez-Fernandez S; Bel J; Puig-Domingo M; Vives-Pi M J Diabetes Res; 2022; 2022():6598600. PubMed ID: 35308094 [TBL] [Abstract][Full Text] [Related]
14. Administration of recombinant human thioredoxin-1 significantly delays and prevents autoimmune diabetes in nonobese diabetic mice through modulation of autoimmunity. Chernatynskaya AV; Looney B; Hu H; Zhu X; Xia CQ Diabetes Metab Res Rev; 2011 Nov; 27(8):809-12. PubMed ID: 22069264 [TBL] [Abstract][Full Text] [Related]
15. Old Dog New Tricks: PLGA Microparticles as an Adjuvant for Insulin Peptide Fragment-Induced Immune Tolerance against Type 1 Diabetes. Liu M; Feng D; Liang X; Li M; Yang J; Wang H; Pang L; Zhou Z; Yang Z; Kong D; Li C Mol Pharm; 2020 Sep; 17(9):3513-3525. PubMed ID: 32787283 [TBL] [Abstract][Full Text] [Related]
17. The targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives. Luce S; Briet C; Bécourt C; Lemonnier F; Boitard C Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():89-97. PubMed ID: 24003925 [TBL] [Abstract][Full Text] [Related]
18. Dysrulation of T cell peripheral tolerance in type 1 diabetes. Tisch R; Wang B Adv Immunol; 2008; 100():125-49. PubMed ID: 19111165 [TBL] [Abstract][Full Text] [Related]